ArticleClinical pharmacology and therapeutics2026
Innovative Drugs Approved in China After Registration Classification Reform: Current Status, Disparities, and Challenges.
Xingyue Zhu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this paperpooled itcites it